PRESS RELEASE published on 07/08/2026 at 18:00, 2 months 26 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Oxurion announces EUR 75,000 capital increase with Atlas Special Opportunities, LLC. Company discloses details following issuance of new shares, increasing total outstanding ordinary shares to 140,734,891 Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion EUR 75,000
BRIEF published on 07/06/2026 at 18:35, 2 months 28 days ago Oxurion launches Exagis' eTMF module to optimize clinical trials Clinical Trials Oxurion EClinical Platform Exaggerate ETMF
BRIEF published on 07/06/2026 at 18:35, 2 months 28 days ago Oxurion Launches Exagis eTMF Module to Enhance Clinical Trials Regulatory Compliance Clinical Trials Software Platform Oxurion ETMF Module
PRESS RELEASE published on 07/06/2026 at 18:30, 2 months 28 days ago Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module Oxurion NV launches Exagis eTMF module, a key milestone in building its eClinical software platform. Designed for clinical research efficiency and regulatory compliance Regulatory Compliance Clinical Research Oxurion NV Exagis ETMF Module EClinical Software Platform
BRIEF published on 06/26/2026 at 18:05, 3 months 7 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/26/2026 at 18:00, 3 months 7 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification regarding shares ownership from Atlas Special Opportunities II, LLC, crossing under the 3% threshold Transparency Notification Euronext Brussels Oxurion NV Shares Ownership Atlas Special Opportunities II LLC
BRIEF published on 06/24/2026 at 18:05, 3 months 9 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Securities Transparency Notification Oxurion Belgian Legislation Atlas Special Opportunities II
PRESS RELEASE published on 06/24/2026 at 18:00, 3 months 9 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV has received a transparency notification regarding changes in shareholding. The company is focused on technology-enabled clinical research and software platform Clinical Research Transparency Notification Shareholding Software Platform Oxurion NV
BRIEF published on 06/19/2026 at 15:50, 3 months 14 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Technology Platform Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/19/2026 at 15:45, 3 months 14 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in share ownership percentage Transparency Notification Euronext Brussels Share Ownership Oxurion NV Atlas Special Opportunities II LLC
Published on 10/03/2026 at 02:35, 19 hours 6 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day 7 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 8 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 8 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 5 hours 56 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 21 hours 46 minutes ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 1 hour ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 1 hour ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 3 hours ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 1 day 3 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/01/2026 at 19:00, 2 days 2 hours ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 3 hours ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 3 hours ago Covivio - Information on total number of voting rights and share capital